Ambrego is a young, global biotechnology company with roots in research conducted by team members since 2018.
We take pride in having talented team members living all around the world.
Ambrego is a young, global biotechnology company with roots in research conducted by team members since 2018.
We take pride in having talented team members living all around the world.
Our Vision To make cancer less deadly by using the latest biotechnology to develop the best possible treatment for most cases of cancer.
Thomas Rogg holds a German Diplom in Computer Science (approximately equivalent to a master's degree) and has extensive knowledge of biochemistry and biotechnology. He has 16 years of experience building companies.
Dr. Michael Hinzmann, appointed Head of Research and Development in 2023, holds a doctorate in organic chemistry and leads the scientific development of our treatment.
We look forward to receiving your application for one of the open positions listed below:
| Position | Time | Location | Link |
|---|---|---|---|
| We currently have no open positions. | |||
Ambrego Inc. is an equal employment opportunity employer and shall make all employment related decisions without regard to race, color, national origin, religion, age, sex, sexual orientation, handicap, veteran status and/or any status or condition protected by law, except where a bona fide occupational qualification exists.